Treatment of chronic prostatitis in Chinese men.
- Author:
Chao-Zhao LIANG
1
;
Hong-Jun LI
;
Zhi-Ping WANG
;
Jun-Ping XING
;
Wei-Lie HU
;
Tao-Fu ZHANG
;
Wei-Wei GE
;
Zong-Yao HAO
;
Xian-Sheng ZHANG
;
Jun ZHOU
;
Yu LI
;
Zheng-Xing ZHOU
;
Zhi-Guo TANG
Author Information
- Publication Type:Journal Article
- MeSH: Adolescent; Adult; Anti-Bacterial Agents; therapeutic use; Bacterial Infections; complications; drug therapy; epidemiology; China; epidemiology; Chronic Disease; Cross-Sectional Studies; Drug Therapy, Combination; Drugs, Chinese Herbal; therapeutic use; Humans; Male; Middle Aged; Prevalence; Prostatitis; drug therapy; epidemiology; microbiology; Surveys and Questionnaires; Treatment Outcome; Young Adult
- From: Asian Journal of Andrology 2009;11(2):153-156
- CountryChina
- Language:English
- Abstract: The aim of this study is to assess the status of treatment of chronic prostatitis (CP) in Chinese men. A population-based cross-sectional survey was performed, in which 15 000 men aged between 15 and 60 years were randomly selected to receive a questionnaire designed to assess National Institutes of Health Chronic Prostatitis Symptoms Index (NIH-CPSI) status, therapeutic efficacy and 28 other items. A total of 12 743 men (84.95%) completed the questionnaire, of whom 1 071 (8.4%) were identified as having prostatitis-like symptoms and 517 (4.5%) were diagnosed with CP according to NIH-CPSI criteria and prostatitis-like symptomatology. Of the CP patients, 372 (65%) underwent long-term routine treatment 12 times per year. Additionally, 217 (72.8%) patients received antibiotic therapy and 215 (79.3%) men showed therapeutic effects. The treatment cost USD 1 151 (8 059 yuan) per person per year on average. Most CP patients received routine treatment, in most cases with antibiotics. Treatment was costly and most CP patients were not satisfied with its effectiveness. Antibacterial treatment might have been effective primarily in patients with bacterial disease.
